FI45332C - Process for the preparation of therapeutically valuable 1-aroyl-2-substituted-5-substituted-3-indoleacetic acids. - Google Patents

Process for the preparation of therapeutically valuable 1-aroyl-2-substituted-5-substituted-3-indoleacetic acids.

Info

Publication number
FI45332C
FI45332C FI300465A FI300465A FI45332C FI 45332 C FI45332 C FI 45332C FI 300465 A FI300465 A FI 300465A FI 300465 A FI300465 A FI 300465A FI 45332 C FI45332 C FI 45332C
Authority
FI
Finland
Prior art keywords
substituted
aroyl
preparation
therapeutically valuable
indoleacetic acids
Prior art date
Application number
FI300465A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI45332B (en
Inventor
Gal George
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI45332B publication Critical patent/FI45332B/fi
Application granted granted Critical
Publication of FI45332C publication Critical patent/FI45332C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
FI300465A 1964-12-31 1965-12-15 Process for the preparation of therapeutically valuable 1-aroyl-2-substituted-5-substituted-3-indoleacetic acids. FI45332C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42250064A 1964-12-31 1964-12-31

Publications (2)

Publication Number Publication Date
FI45332B FI45332B (en) 1972-01-31
FI45332C true FI45332C (en) 1972-05-10

Family

ID=23675168

Family Applications (1)

Application Number Title Priority Date Filing Date
FI300465A FI45332C (en) 1964-12-31 1965-12-15 Process for the preparation of therapeutically valuable 1-aroyl-2-substituted-5-substituted-3-indoleacetic acids.

Country Status (11)

Country Link
BE (1) BE674565A (en)
BR (1) BR6575767D0 (en)
CH (1) CH469707A (en)
DK (1) DK114695B (en)
ES (1) ES321429A1 (en)
FI (1) FI45332C (en)
FR (1) FR1503528A (en)
GB (1) GB1105679A (en)
IL (1) IL24804A (en)
NL (1) NL6517259A (en)
SE (5) SE304511B (en)

Also Published As

Publication number Publication date
ES321429A1 (en) 1966-06-16
FI45332B (en) 1972-01-31
SE304511B (en) 1968-09-30
SE332635B (en) 1971-02-15
IL24804A (en) 1970-03-22
GB1105679A (en) 1968-03-13
FR1503528A (en) 1967-12-01
BE674565A (en) 1966-06-30
SE332636B (en) 1971-02-15
DK114695B (en) 1969-07-28
NL6517259A (en) 1966-07-04
CH469707A (en) 1969-03-15
BR6575767D0 (en) 1973-09-06
SE337822B (en) 1971-08-23
SE337375B (en) 1971-08-09

Similar Documents

Publication Publication Date Title
FI48590C (en) Process for the preparation of therapeutically useful azaspiroalkandion compounds.
DK117353B (en) Process for the preparation of substituted arylacethydroxamic acids.
FI47364C (en) Process for the preparation of therapeutically valuable 3-indolyl-aliphatic-acid compounds.
FI45970C (en) Process for the preparation of therapeutically valuable 1-substituted-2-aryl-4- or 5-nitroimidazoles.
FI48722C (en) Process for the preparation of 3-methylpentenes.
FI46069C (en) A process for the preparation of a therapeutically useful 1-R-2-formyl-5-nitroimidazole.
DK113645B (en) Process for the preparation of therapeutically effective indolyl-3-alkane-carboxylic acids.
DK113859B (en) Process for the preparation of hydroxamic acids.
FI46965C (en) Process for the preparation of 5-phenyl-1,4-benzodiazepine-4-oxides
NL142942C (en) PROCESS FOR THE CONTINUOUS PREPARATION OF SATURATED ALCAANDICARBON ACIDS.
DK126584B (en) Process for the preparation of D-2-phenoxypropionic acids.
FI44622C (en) Process for the preparation of therapeutically valuable substituted naphthalene derivatives.
OA03369A (en) Process for the preparation of benzene-sulfonyl-ureas.
FI44625C (en) Process for the preparation of new therapeutically valuable d-threo-1-phenyl-2-amino-1,3-propanediol derivatives
FI44620C (en) Process for the preparation of sulfamylanthranilic acid amides.
FI43878C (en) Process for the preparation of antidiabetically effective 2-benzenesulfonamidopyrimidines
DK122756B (en) Analogous process for the preparation of 2-alkoxy-5-trifluoromethylbenzoic acids.
DK111143B (en) Process for the preparation of sulfamylanthranilic acids.
FI47097C (en) Process for the preparation of therapeutically effective 1-p-chlorobenzoyl-2-methyl-5-methoxy-3-indolylacetic acid.
FI45332C (en) Process for the preparation of therapeutically valuable 1-aroyl-2-substituted-5-substituted-3-indoleacetic acids.
DK113149B (en) Process for the preparation of sulfamylanthranilic acids.
DK117488C (en) Process for the preparation of therapeutically active 2α-3α-epithio-5α-androstanes.
FI46966C (en) Process for the preparation of therapeutically useful 1,3-dihydro-3-hydroxy-1,4-benzodiazepin-2-ones
DK122880B (en) Process for the preparation of sulfamylanthranilic acids.
FI42318C (en) Process for the preparation of new unsaturated amino compounds